{"pmid":32380008,"pmcid":"PMC7198148","title":"Resumption of daily services in a gastroenterology department in Guangzhou, China, in the wake of COVID-19.","text":["Resumption of daily services in a gastroenterology department in Guangzhou, China, in the wake of COVID-19.","Lancet Gastroenterol Hepatol","Han, Jing","Zhu, Liguo","Wang, Ying","Zeng, Zhirong","Zhang, Shenghong","32380008"],"journal":"Lancet Gastroenterol Hepatol","authors":["Han, Jing","Zhu, Liguo","Wang, Ying","Zeng, Zhirong","Zhang, Shenghong"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32380008","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/S2468-1253(20)30133-3","locations":["Guangzhou","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666597097318645761,"score":9.490897,"similar":[{"pmid":32281517,"title":"The daily impact of COVID-19 in gastroenterology.","text":["The daily impact of COVID-19 in gastroenterology.","A new strain of coronavirus, called SARS-CoV-2, emerged in Wuhan, China, in December 2019, probably originating from a wild-animal contamination. Since then, the situation rapidly evolved from a cluster of patients with pneumonia, to a regional epidemic and now to a pandemic called COrona VIrus Disease 2019 (COVID-19). This evolution is related to the peculiar modes of transmission of the disease and to the globalization and lifestyle of the 21st century that created the perfect scenario for virus spread. Even though research has not evidenced particular susceptibility of inflammatory bowel disease (IBD) patients to SARS-CoV-2 infection, immunosuppressive and immunomodulatory treatments were considered potential risk factors. In this context, initiating treatments with these agents should be cautiously weighted and regular ongoing treatments shall be continued, while the dose of corticosteroids should be reduced whenever possible. Due to the increased risk of contamination, elective endoscopic procedures and surgeries should be postponed and IBD online appointments shall be considered. IBD patients shall also follow the recommendations provided to the general population, such as minimization of contact with infected or suspected patients and to wash hands frequently. In the absence of effective treatments and vaccines, this pandemic can only be controlled through prevention of SARS-CoV-2 transmission with the main objectives of providing patients the best healthcare possible and reduce mortality.","United European Gastroenterol J","Magro, Fernando","Abreu, Candida","Rahier, Jean-Francois","32281517"],"abstract":["A new strain of coronavirus, called SARS-CoV-2, emerged in Wuhan, China, in December 2019, probably originating from a wild-animal contamination. Since then, the situation rapidly evolved from a cluster of patients with pneumonia, to a regional epidemic and now to a pandemic called COrona VIrus Disease 2019 (COVID-19). This evolution is related to the peculiar modes of transmission of the disease and to the globalization and lifestyle of the 21st century that created the perfect scenario for virus spread. Even though research has not evidenced particular susceptibility of inflammatory bowel disease (IBD) patients to SARS-CoV-2 infection, immunosuppressive and immunomodulatory treatments were considered potential risk factors. In this context, initiating treatments with these agents should be cautiously weighted and regular ongoing treatments shall be continued, while the dose of corticosteroids should be reduced whenever possible. Due to the increased risk of contamination, elective endoscopic procedures and surgeries should be postponed and IBD online appointments shall be considered. IBD patients shall also follow the recommendations provided to the general population, such as minimization of contact with infected or suspected patients and to wash hands frequently. In the absence of effective treatments and vaccines, this pandemic can only be controlled through prevention of SARS-CoV-2 transmission with the main objectives of providing patients the best healthcare possible and reduce mortality."],"journal":"United European Gastroenterol J","authors":["Magro, Fernando","Abreu, Candida","Rahier, Jean-Francois"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281517","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1177/2050640620920157","keywords":["gastroenterology","endoscopy","epidemiology","immunology","inflammatory bowel disease"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138491433517057,"score":66.10456},{"pmid":32316737,"title":"Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG.","text":["Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG.","The set of measures proposed by SEPD, AEEH, GETECCU and AEG are aimed to help departments in their resumption of usual activity. We have prepared a number of practical recommendations regarding patient management and the stepwise resumption of healthcare activity. These recommendations are based on the sparse, changing evidence available, and will be updated in the future according to daily needs and the availability of expendable materials to suit them; in each department they will be implemented depending upon the cumulative incidence of SARS-CoV-2 infection in each region, and the burden the pandemic has represented for each hospital. The general objectives of these recommendations include: * To protect our patients against the risks of infection with SARS-CoV-2 and to provide them with high-quality care. * To protect all healthcare professionals against the risks of infection with SARS-CoV-2. * To resume normal functioning of our departments in a setting of ongoing risk for infection with SARS-CoV-2.","Rev Esp Enferm Dig","Crespo, Javier","Andrade, Raul","Alberca de Las Parras, Fernando","Balaguer, Francesc","Barreiro-de Acosta, Manuel","Bujanda, Luis","Gutierrez, Ana","Jorquera, Francisco","Iglesias-Garcia, Julio","Sanchez-Yague, Andres","Calleja, Jose Luis","32316737"],"abstract":["The set of measures proposed by SEPD, AEEH, GETECCU and AEG are aimed to help departments in their resumption of usual activity. We have prepared a number of practical recommendations regarding patient management and the stepwise resumption of healthcare activity. These recommendations are based on the sparse, changing evidence available, and will be updated in the future according to daily needs and the availability of expendable materials to suit them; in each department they will be implemented depending upon the cumulative incidence of SARS-CoV-2 infection in each region, and the burden the pandemic has represented for each hospital. The general objectives of these recommendations include: * To protect our patients against the risks of infection with SARS-CoV-2 and to provide them with high-quality care. * To protect all healthcare professionals against the risks of infection with SARS-CoV-2. * To resume normal functioning of our departments in a setting of ongoing risk for infection with SARS-CoV-2."],"journal":"Rev Esp Enferm Dig","authors":["Crespo, Javier","Andrade, Raul","Alberca de Las Parras, Fernando","Balaguer, Francesc","Barreiro-de Acosta, Manuel","Bujanda, Luis","Gutierrez, Ana","Jorquera, Francisco","Iglesias-Garcia, Julio","Sanchez-Yague, Andres","Calleja, Jose Luis"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32316737","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.17235/reed.2020.7141/2020","topics":["Prevention"],"weight":1,"_version_":1666138493727801344,"score":63.94552},{"pmid":32409107,"title":"Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG.","text":["Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG.","The set of measures proposed by SEPD, AEEH, GETECCU and AEG are aimed to help departments in their resumption of usual activity. We have prepared a number of practical recommendations regarding patient management and the stepwise resumption of healthcare activity. These recommendations are based on the sparse, changing evidence available, and will be updated in the future according to daily needs and the availability of expendable materials to suit them; in each department they will be implemented depending upon the cumulative incidence of SARS-CoV-2 infection in each region, and the burden the pandemic has represented for each hospital. The general objectives of these recommendations include: (a)To protect our patients against the risks of infection with SARS-CoV-2 and to provide them with high-quality care. (b)To protect all healthcare professionals against the risks of infection with SARS-CoV-2. (c)To resume normal functioning of our departments in a setting of ongoing risk for infection with SARS-CoV-2.","Gastroenterol Hepatol","Crespo, Javier","Andrade, Raul","Alberca de Las Parras, Fernando","Balaguer, Francesc","Barreiro-de Acosta, Manuel","Bujanda, Luis","Gutierrez, Ana","Jorquera, Francisco","Iglesias-Garcia, Julio","Sanchez-Yague, Andres","Calleja, Jose Luis","32409107"],"abstract":["The set of measures proposed by SEPD, AEEH, GETECCU and AEG are aimed to help departments in their resumption of usual activity. We have prepared a number of practical recommendations regarding patient management and the stepwise resumption of healthcare activity. These recommendations are based on the sparse, changing evidence available, and will be updated in the future according to daily needs and the availability of expendable materials to suit them; in each department they will be implemented depending upon the cumulative incidence of SARS-CoV-2 infection in each region, and the burden the pandemic has represented for each hospital. The general objectives of these recommendations include: (a)To protect our patients against the risks of infection with SARS-CoV-2 and to provide them with high-quality care. (b)To protect all healthcare professionals against the risks of infection with SARS-CoV-2. (c)To resume normal functioning of our departments in a setting of ongoing risk for infection with SARS-CoV-2."],"journal":"Gastroenterol Hepatol","authors":["Crespo, Javier","Andrade, Raul","Alberca de Las Parras, Fernando","Balaguer, Francesc","Barreiro-de Acosta, Manuel","Bujanda, Luis","Gutierrez, Ana","Jorquera, Francisco","Iglesias-Garcia, Julio","Sanchez-Yague, Andres","Calleja, Jose Luis"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409107","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.gastrohep.2020.04.001","keywords":["gastroenterology departments","recomendaciones","recommendations","restablecimiento","resumption","sars-cov-2","servicios de digestivo"],"locations":["b)To"],"topics":["Prevention"],"weight":1,"_version_":1666897319124008960,"score":63.94552},{"pmid":32240078,"title":"COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020.","text":["COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020.","During January 26-February 10, 2020, an outbreak of 2019 novel coronavirus disease in an air-conditioned restaurant in Guangzhou, China, involved 3 family clusters. The airflow direction was consistent with droplet transmission. To prevent the spread of the virus in restaurants, we recommend increasing the distance between tables and improving ventilation.","Emerg Infect Dis","Lu, Jianyun","Gu, Jieni","Li, Kuibiao","Xu, Conghui","Su, Wenzhe","Lai, Zhisheng","Zhou, Deqian","Yu, Chao","Xu, Bin","Yang, Zhicong","32240078"],"abstract":["During January 26-February 10, 2020, an outbreak of 2019 novel coronavirus disease in an air-conditioned restaurant in Guangzhou, China, involved 3 family clusters. The airflow direction was consistent with droplet transmission. To prevent the spread of the virus in restaurants, we recommend increasing the distance between tables and improving ventilation."],"journal":"Emerg Infect Dis","authors":["Lu, Jianyun","Gu, Jieni","Li, Kuibiao","Xu, Conghui","Su, Wenzhe","Lai, Zhisheng","Zhou, Deqian","Yu, Chao","Xu, Bin","Yang, Zhicong"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240078","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.3201/eid2607.200764","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","droplet transmission","family cluster","outbreak","respiratory infections","restaurant","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["Guangzhou","China","Restaurant","Guangzhou","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Transmission"],"weight":1,"_version_":1666138490277986305,"score":44.888992},{"pmid":32460357,"title":"Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.","text":["Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.","Coronavirus disease 2019 (COVID-19) is a respiratory disorder caused by the highly contagious SARS-CoV-2. The immunopathological characteristics of COVID-19 patients, either systemic or local, have not been thoroughly studied. In the present study, we analyzed both the changes in the number of various immune cell types as well as cytokines important for immune reactions and inflammation. Our data indicate that patients with severe COVID-19 exhibited an overall decline of lymphocytes including CD4+ and CD8+ T cells, B cells, and NK cells. The number of immunosuppressive regulatory T cells was moderately increased in patients with mild COVID-19. IL-6, IL-10, and C-reactive protein were remarkably up-regulated in patients with severe COVID-19. In conclusion, our study shows that the comprehensive decrease of lymphocytes, the elevation of IL-6, IL-10, and C-reactive protein are reliable indicators of severe COVID-19.","Immunology","Tan, Mingkai","Liu, Yanxia","Zhou, Ruiping","Deng, Xilong","Li, Fang","Liang, Kaiyan","Shi, Yaling","32460357"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory disorder caused by the highly contagious SARS-CoV-2. The immunopathological characteristics of COVID-19 patients, either systemic or local, have not been thoroughly studied. In the present study, we analyzed both the changes in the number of various immune cell types as well as cytokines important for immune reactions and inflammation. Our data indicate that patients with severe COVID-19 exhibited an overall decline of lymphocytes including CD4+ and CD8+ T cells, B cells, and NK cells. The number of immunosuppressive regulatory T cells was moderately increased in patients with mild COVID-19. IL-6, IL-10, and C-reactive protein were remarkably up-regulated in patients with severe COVID-19. In conclusion, our study shows that the comprehensive decrease of lymphocytes, the elevation of IL-6, IL-10, and C-reactive protein are reliable indicators of severe COVID-19."],"journal":"Immunology","authors":["Tan, Mingkai","Liu, Yanxia","Zhou, Ruiping","Deng, Xilong","Li, Fang","Liang, Kaiyan","Shi, Yaling"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32460357","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/imm.13223","keywords":["covid-19","cytokines","immune cells","inflammation","sars-cov-2"],"locations":["Guangzhou","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1668141322598350848,"score":44.025867}]}